Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Quality of Life Research
Erschienen in: Quality of Life Research 11/2015

01.11.2015

Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study

verfasst von: Boon-How Chew

Erschienen in: Quality of Life Research | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study examined the association between medication adherence (MA) and health-related quality of life (HRQoL) among the adult type 2 diabetes mellitus at the primary care level.

Methods

In this cross-sectional study, the 8-item Morisky Medication Adherence Scale (MMAS) was the main independent variable and the World Health Organization Quality of Life-Brief the dependent variable. Besides socio-demographic data, diabetes-related distress (DRD) and depression (DS) were included as covariates. Independent association between the MMAS score and HRQoL was done using multiple linear regression.

Results

The participants’ response rate was 93.1 % (700/752). Majorities were female (52.8 %), Malay (52.9 %) and married (79.1 %). The mean (SD) for age and the MMAS score was 56.9 (10.18) and 5.6 (1.42), respectively. MMAS total score correlated significantly with all HRQoL domains: overall QoL (OQoL) (r = 0.17), physical QoL (r = 0.11), psychological QoL (r = 0.10), social relationship QoL (r = 0.15) and environmental QoL (EQoL) (r = 0.18). After adjustment for covariates (age, gender, ethnicity, religion, education, income, exercise, macrovascular complications, DRD and DS), MA had persistent effects on OQoL (B = 0.53, 95 % CI 0.012–1.048) and EQoL (B = 0.95, 95 % CI 0.235–1.667).

Conclusion

MA showed prevalent correlation and positive effects on the domains of HRQoL. Despite the small effects of MA on HRQoL, the sheer presence of the independent effects provides healthcare providers good reason for initiative and intervention to improve MA, which would improve quality of life.
Literatur
1.
Asche, C., LaFleur, J., & Conner, C. (2011). A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics, 33, 74–109.CrossRefPubMed
2.
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.CrossRefPubMed
3.
Manan, M. M., Husin, A. R., Alkhoshaiban, A. S., Al-Worafi, Y. M., & Ming, L. C. (2014). Interplay between oral hypoglycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. Journal of Clinical and Diagnostic Research, 8, JC05–JC09.PubMedCentralPubMed
4.
Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42, 102–109.CrossRefPubMed
5.
Martinez, Y. V., Prado-Aguilar, C. A., Rascon-Pacheco, R. A., & Valdivia-Martinez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8, 164.PubMedCentralCrossRefPubMed
6.
Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348–354.PubMedCentralCrossRefPubMed
7.
Al-Qazaz, H. K., Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice, 90, 216–221.PubMedCentralCrossRefPubMed
8.
Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13, 299–310.CrossRefPubMed
9.
Group, T.W. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28, 551–558.CrossRef
10.
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale. Diabetes Care, 28, 626–631.CrossRefPubMed
11.
El Achhab, Y., Nejjari, C., Chikri, M., & Lyoussi, B. (2008). Disease-specific health-related quality of life instruments among adults diabetic: A systematic review. Diabetes Research and Clinical Practice, 80, 171–184.CrossRefPubMed
12.
Fisher, L., Hessler, D. M., Polonsky, W. H., & Mullan, J. (2012). When is diabetes distress clinically meaningful?: Establishing cut points for the Diabetes Distress Scale. Diabetes Care, 35, 259–264.PubMedCentralCrossRefPubMed
13.
Chew, B. H., Mukhtar, F., Mohd-Sidik, S., Paimin, F., Noor-Hasliza Hassan, N.-H., Jamaludin, N.-K. (2015). The 17-items Diabetes Distress Scale (DDS): Translation and validation of the Malay version. Malays Fam Physician (submitted).
14.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613.PubMedCentralCrossRefPubMed
15.
Sherina, M. S., Arroll, B., & Goodyear-Smith, F. (2012). Criterion validity of the PHQ-9 (Malay version) in a primary care clinic in Malaysia. Medical Journal of Malaysia, 67, 309–315.PubMed
16.
WHO Consultation. (1999. Report no. 99.2.). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization.
17.
Ministry of Health, Malaysia. (2009). Management of type 2 diabetes mellitus. Putrajaya: Technology, Health Section, Assessment Division, Medical Development.
18.
American Diabetes Association. (2015). Standards of medical care in diabetes—2015. Diabetes Care, 38, S1–S93.
19.
Fisher, L., Mullan, J. T., Arean, P., Glasgow, R. E., Hessler, D., & Masharani, U. (2010). Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care, 33, 23–28.PubMedCentralCrossRefPubMed
20.
van Bastelaar, K. M., Pouwer, F., Geelhoed-Duijvestijn, P. H., Tack, C. J., Bazelmans, E., Beekman, A. T., et al. (2010). Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes. Diabetic Medicine, 27, 798–803.CrossRefPubMed
21.
Ahmad, N. S., Ramli, A., Islahudin, F., & Paraidathathu, T. (2013). Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference Adherence, 7, 525–530.PubMedCentralPubMed
22.
(2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. In NICE clinical guideline 76. Manchester, UK.
23.
Vermeire, E., Wens, J., Van Royen, P., Biot, Y., Hearnshaw, H., & Lindenmeyer, A. (2005). Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online), CD003638–CD003638.
24.
Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65, 314–322.CrossRefPubMed
25.
Non-Communicable Disease Section, Disease Control Division, Department of Public Health. National Diabetes Registry Report, Volume 1: 2009–2012 (2013).
Metadaten
Titel
Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study
verfasst von
Boon-How Chew
Publikationsdatum
01.11.2015
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 11/2015
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1006-7

Weitere Artikel der Ausgabe 11/2015

Quality of Life Research 11/2015 Zur Ausgabe

OriginalPaper

Six years beyond pediatric trauma: child and parental ratings of children’s health-related quality of life in relation to parental mental health

OriginalPaper

Long-term health-related quality of life for patients with Hirschsprung’s disease at 5 years after transanal endorectal pull-through operation

OriginalPaper

Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant

OriginalPaper

Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease

OriginalPaper

Complex coevolution of depression and health-related quality of life in old age

OriginalPaper

Benefit finding predicts depressive and anxious symptoms in women with breast cancer